Wellinghoff Darryl 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Mar 16, 2020
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Common Stock
[F1]2020-03-13$3.40/sh+483$1,642→ 9,011 total - Award
Stock Option (Right to Buy)
[F2]2020-03-13+483→ 483 totalExercise: $4.00Exp: 2030-03-13→ Common Stock (483 underlying)
Footnotes (2)
- [F1]These shares were acquired on 03/13/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Signature
/s/ Ryan Murr, as attorney-in-fact for Darryl Wellinghoff|2020-03-16